The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AADI BIOSCIENCES INC COM 00032Q104   19,622,228 1,849,402 SH   SOLE   1,849,402 0 0
ACLARIS THERAPEUTICS COM 00461U105   4,016,250 255,000 SH   SOLE   255,000 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106   11,246,925 217,500 SH   SOLE   217,500 0 0
ARGEN SE SPONSORED ADR 04016X101   1,932,033 5,100 SH   SOLE   5,100 0 0
ARROWHEAD PHARMACEUTICALS INC COM 04280A100   1,664,136 41,029 SH   SOLE   41,029 0 0
BELLUS HEALTH INC COM NEW 07987C204   5,199,150 632,500 SH   SOLE   632,500 0 0
BIOATLA INC COM 09077B104   4,125,000 500,000 SH   SOLE   500,000 0 0
CELLDEX THERAPEUTICS INC COM NEW 15117B202   5,125,550 115,000 SH   SOLE   115,000 0 0
CYMABAY THERAPEUTICS INC. COMMON STOCK COM 23257D103   6,364,050 1,015,000 SH   SOLE   1,015,000 0 0
EYEPOINT PHARMACEUTICALS INC COM NEW 30233G209   1,061,886 303,396 SH   SOLE   303,396 0 0
FULCRUM THERAPEUTICS INC COM 359616109   1,346,800 185,000 SH   SOLE   185,000 0 0
GH RESEARCH PLC ORDINARY SHARES G3855L106   2,364,390 243,250 SH   SOLE   243,250 0 0
HORIZON THERAPEUTICS PLC SHS G46188101   682,800 6,000 SH   SOLE   6,000 0 0
IMARA INC COM 45249V107   182,017 44,503 SH   SOLE   44,503 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100   981,753 153,639 SH   SOLE   153,639 0 0
IVERIC BIO INC COM 46583P102   7,718,305 360,500 SH   SOLE   360,500 0 0
KEROS THERAPEUTICS INC COM 492327101   3,841,600 80,000 SH   SOLE   80,000 0 0
KINNATE BIOPHARMA INC COM 49705R105   30,500 5,000 SH   SOLE   5,000 0 0
KURA ONCOLOGY INC. COMMON STOCK COM 50127T109   6,223,615 501,500 SH   SOLE   501,500 0 0
MERSANA THERAPEUTICS INC COM 59045L106   5,567,000 950,000 SH   SOLE   950,000 0 0
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 61559X104   981,750 93,500 SH   SOLE   93,500 0 0
NUVATION BIO INC *W EXP 07/07/2027 67080N119   13,125 90,832 SH   SOLE   90,832 0 0
PMV PHARMACEUTICALS INC COM 69353Y103   1,343,898 154,471 SH   SOLE   154,471 0 0
PROTHENA CORPORATION PLC SHS G72800108   560,325 9,300 SH   SOLE   9,300 0 0
PYXIS ONCOLOGY INC COMMON STOCK 747324101   896,672 669,158 SH   SOLE   669,158 0 0
REZOLUTE INC COM NEW 76200L309   869,400 420,000 SH   SOLE   420,000 0 0
ROCKET PHARMACEUTICALS INC COM 77313F106   5,088,200 260,000 SH   SOLE   260,000 0 0
SAREPTA TEHRAPEUTICS INC COM 803607100   8,746,650 67,500 SH   SOLE   67,500 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105   8,261,426 324,614 SH   SOLE   324,614 0 0
TERNS PHARMACEUTICALS INC COM 880881107   11,198,000 1,100,000 SH   SOLE   1,100,000 0 0
UNITED THERAPEUTICS CORP DEL COM 91307C102   9,176,970 33,000 SH   SOLE   33,000 0 0
VAXCYTE INC COM 92243G108   6,928,775 144,500 SH   SOLE   144,500 0 0
VENTYX BIOSCIENCES INC COM 92332V107   7,558,095 290,500 SH   SOLE   290,500 0 0
VIRIDIAN THERAPEUTICS INC COM 92790C104   11,581,765 396,500 SH   SOLE   396,500 0 0